Cellyan Biotechnology Co earnings were -$27.1k for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest HKPD earnings report on Mar 31, 2025 announced Q1 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, HKPD reported annual earnings of -$27.1k, with -102% growth.
Cellyan Biotechnology Co Earnings Reports & History FAQ
What were Cellyan Biotechnology Co's earnings last quarter?
Cellyan Biotechnology Co (NASDAQ: HKPD) reported Q1 2025 earnings per share (EPS) of N/A, up N/A year over year. Total HKPD earnings for the quarter were N/A. In the same quarter last year, Cellyan Biotechnology Co's earnings per share (EPS) was N/A.
Is Cellyan Biotechnology Co profitable or losing money?
As of the last Cellyan Biotechnology Co earnings report, Cellyan Biotechnology Co is currently losing money. Cellyan Biotechnology Co's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$27.06 thousand, a 102.03% decrease year over year.
What was HKPD's earnings growth in the past year?
As of Cellyan Biotechnology Co's earnings date in Q1 2026, Cellyan Biotechnology Co's earnings has grown year over year. HKPD earnings in the past year totalled -$27.06 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.